NLRP3, the most extensively studied inflammasome, has been implicated in the pathogenesis of AD (10, 12) This review summarizes the structure, activation mechanisms, and involvement of the NLRP3 inflammasome in AD, as well as potential therapeutic strategies targeting this inflammasome. Here, NLRP3 is linked to Alzheimer disease.